Analyst rating accuracy & track record
Nathan Weinstein is an equity research analyst at Aegis Capital. Bullish Whales has scored 21 of their stock calls across 13 companies. Their picks beat their sector 26% of the time over the next 12 months, and their price targets were reached 26% of the time within a year.
Track record
Bullish Whales has scored 21 of Nathan Weinstein's stock calls across 13 companies, dating back to 2020. Their rated stocks beat their own sector 26% of the time over the next 12 months. On a typical call, a Weinstein pick returned −34.4% more than its sector over the following year.
Of the scored calls, 21 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.
Coverage & ratings
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 EVGNEvogene | Buy | $8.00 | Sep 2022 | −34.2% | Miss |
 DRIODarioHealth Corp | Buy | $15.00 | Aug 2022 | −44.8% | Miss |
 STXSStereotaxis Inc | Buy | $6.00 | Jul 2022 | −51.6% | Miss |
| DRIODarioHealth Corp | Buy | $20.00 | May 2022 | −48.7% | Miss |
 ORMPOramed Pharmaceuticals Inc | Buy | $30.00 | May 2022 | −25.6% | Miss |
 MDWDMediwound Ltd | Buy | $7.00 | Mar 2022 | −11.3% | Miss |
 SCNIScinai Immunotherapeutics Ltd | Buy | $7.00 | Jan 2022 | −84.7% | Miss |
| DRIODarioHealth Corp | Buy | $25.00 | Jan 2022 | −30.9% | Miss |
| ORMPOramed Pharmaceuticals Inc | Buy | $35.00 | Nov 2021 | −71.4% | Miss |
 IINNInspira Technologies Oxy BHN Ltd | Buy | $10.00 | Nov 2021 | −62.1% | Miss |
| DRIODarioHealth Corp | Buy | $28.00 | Aug 2021 | −55.8% | Miss |
 ATAIATAI Life Sciences BV | Buy | $27.00 | Aug 2021 | −71.4% | Miss |
| ORMPOramed Pharmaceuticals Inc | Buy | $20.00 | Jun 2021 | −75.7% | Hit |
 SCYXScynexis Inc | Buy | $35.00 | Jun 2021 | −84.9% | Miss |
| SCYXScynexis Inc | Buy | $40.00 | Apr 2021 | −74.5% | Miss |
| DRIODarioHealth Corp | Buy | $35.00 | Feb 2021 | −85.1% | Miss |
| ORMPOramed Pharmaceuticals Inc | Buy | $12.00 | Jan 2021 | +5.2% | Hit |
 BMRABiomerica Inc | Buy | $11.00 | Oct 2020 | −24.7% | Miss |
 ICCCImmuCell Corporation | Buy | $14.00 | Jul 2020 | +34.4% | Miss |
 AMRNAmarin Corporation PLC | Buy | $11.00 | May 2020 | −62.6% | Miss |
 EKSOEkso Bionics Holdings Inc | Buy | $15.00 | Apr 2020 | +51.5% | Miss |
Nathan Weinstein: analyst track record FAQ
Is Nathan Weinstein a good stock analyst?
Yes, by track record. Nathan Weinstein ranks number 338 of 347 of the analysts Bullish Whales scores, with a BW Score of 0 out of 100. Past results do not guarantee future ones.
What is Nathan Weinstein's win rate?
Nathan Weinstein's win rate is 26%. Across 21 scored calls, their rated stocks beat their sector 26% of the time over the next 12 months. On a typical call they returned −34.4% more than the sector.
What stocks and sectors does Nathan Weinstein cover?
Nathan Weinstein covers 13 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.
Are Nathan Weinstein's price targets accurate?
Nathan Weinstein's price targets are reached within 12 months 26% of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.
How accurate are Wall Street analyst price targets?
Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.
Should I follow Nathan Weinstein's stock ratings?
Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.
How does Bullish Whales score analyst accuracy?
Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.
How does Nathan Weinstein rank among Wall Street analysts?
Nathan Weinstein ranks number 338 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.